A new perspective on calcium channel blockers in vasospastic angina.
作者信息
Kim Hack-Lyoung
机构信息
Division of Cardiology, Department of Internal Medicine, Seoul Metropolitan Government- Seoul National University Boramae Medical Center, Seoul, Korea.
出版信息
Korean J Intern Med. 2021 Jan;36(1):63-64. doi: 10.3904/kjim.2020.628. Epub 2021 Jan 1.
Abstract
摘要
相似文献
1
A new perspective on calcium channel blockers in vasospastic angina.钙通道阻滞剂在血管痉挛性心绞痛治疗中的新视角。
Korean J Intern Med. 2021 Jan;36(1):63-64. doi: 10.3904/kjim.2020.628. Epub 2021 Jan 1.
2
Vasospastic angina and Ca channel blockers.变异性心绞痛与钙通道阻滞剂
Curr Hypertens Rev. 2013 Aug;9(3):219-23. doi: 10.2174/1573402110666140131161338.
3
Clinical efficacy of benidipine for vasospastic angina pectoris.贝尼地平治疗血管痉挛性心绞痛的临床疗效。
Arzneimittelforschung. 2007;57(1):20-5. doi: 10.1055/s-0031-1296581.
4
Prognostic factors for the long-term survival in patients with vasospastic angina--analysis of effects of patients' characteristics and therapeutic drugs.伴有血管痉挛性心绞痛患者长期生存的预后因素——患者特征和治疗药物效果分析。
J Cardiol. 2009 Aug;54(1):10-20. doi: 10.1016/j.jjcc.2009.02.013. Epub 2009 Apr 1.
5
Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.贝尼地平及其他一些钙通道阻滞剂对变异性心绞痛患者预后的影响。采用麦角新碱冠状动脉痉挛诱发试验评估的队列研究。
Arzneimittelforschung. 2007;57(9):573-81. doi: 10.1055/s-0031-1296652.
6
Pharmacotherapy of Vasospastic Angina.变异性心绞痛的药物治疗
J Cardiovasc Pharmacol Ther. 2016 Sep;21(5):439-51. doi: 10.1177/1074248416640161. Epub 2016 Apr 13.
7
Coronary artery vasoconstriction and its treatment with calcium channel blockers.
Ala J Med Sci. 1985 Jul;22(3):271-4.
8
[Calcium channel blockers in ischemic cardiopathies].[缺血性心脏病中的钙通道阻滞剂]
Therapie. 1989 May-Jun;44(3):155-9.
9
Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease.抗痉挛药物（钙拮抗剂和/或硝酸异山梨酯）对无血流动力学显著意义的冠状动脉疾病的冠状动脉痉挛性心绞痛患者高敏C反应蛋白的影响。
Am J Cardiol. 2005 Jan 1;95(1):84-7. doi: 10.1016/j.amjcard.2004.08.064.
10
Coronary vasospasm at the site of myocardial bridge--report of two cases.心肌桥部位的冠状动脉痉挛——两例报告
Angiology. 1998 Aug;49(8):659-63. doi: 10.1177/000331979804900812.
引用本文的文献
1
Drug-Induced Myocardial Infarction: A Review of Pharmacological Triggers and Pathophysiological Mechanisms.药物性心肌梗死：药理触发因素与病理生理机制综述
J Cardiovasc Dev Dis. 2024 Dec 18;11(12):406. doi: 10.3390/jcdd11120406.
2
Acute coronary syndrome due to coronary vasospasm: a case report.因冠状动脉痉挛导致的急性冠状动脉综合征：一例报告。
Future Cardiol. 2024;20(11-12):613-618. doi: 10.1080/14796678.2024.2392995. Epub 2024 Sep 4.
3
Ischaemia with no obstructive coronary arteries: a review with focus on the Asian population.无阻塞性冠状动脉病变的缺血：一篇以亚洲人群为重点的综述。
Singapore Med J. 2024 Jul 1;65(7):380-388. doi: 10.4103/singaporemedj.SMJ-2023-116. Epub 2024 Jul 8.
4
Vasospastic angina: a review on diagnostic approach and management.血管痉挛性心绞痛：诊断方法和治疗的综述。
Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241230400. doi: 10.1177/17539447241230400.
5
Diltiazem is a useful and effective medication for reversal of coronary artery spasm-induced complete atrioventricular block: A case report.地尔硫䓬是一种用于逆转冠状动脉痉挛所致完全性房室传导阻滞的有效药物：一例病例报告。
Front Cardiovasc Med. 2023 Apr 3;10:1134658. doi: 10.3389/fcvm.2023.1134658. eCollection 2023.
6
Comparison of various calcium antagonist on vasospastic angina: a systematic review.各种钙拮抗剂治疗血管痉挛性心绞痛的比较：系统评价。
Open Heart. 2023 Jan;10(1). doi: 10.1136/openhrt-2022-002179.
本文引用的文献
1
Comparison of calcium-channel blockers for long-term clinical outcomes in patients with vasospastic angina.钙通道阻滞剂治疗血管痉挛性心绞痛患者长期临床结局的比较。
Korean J Intern Med. 2021 Jan;36(1):124-134. doi: 10.3904/kjim.2019.308. Epub 2020 Feb 24.
2
Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis.钙通道阻滞剂对痉挛性心绞痛患者预后的影响——一项荟萃分析。
Circ J. 2010 Sep;74(9):1943-50. doi: 10.1253/circj.cj-10-0292. Epub 2010 Jul 21.
3
Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine.贝尼地平对变异性心绞痛患者的预后影响：与地尔硫䓬和氨氯地平的比较。
J Cardiovasc Pharmacol. 2008 Mar;51(3):253-7. doi: 10.1097/FJC.0b013e3181624b05.
4
Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test.贝尼地平及其他一些钙通道阻滞剂对变异性心绞痛患者预后的影响。采用麦角新碱冠状动脉痉挛诱发试验评估的队列研究。
Arzneimittelforschung. 2007;57(9):573-81. doi: 10.1055/s-0031-1296652.
5
Calcium-channel modulators for cardiovascular disease.
Expert Opin Emerg Drugs. 2006 Mar;11(1):49-73. doi: 10.1517/14728214.11.1.49.
6
Coronary spasm: clinical features and pathogenesis.冠状动脉痉挛：临床特征与发病机制
Intern Med. 1997 Nov;36(11):760-5. doi: 10.2169/internalmedicine.36.760.
7
Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group.
J Am Coll Cardiol. 1993 May;21(6):1365-70. doi: 10.1016/0735-1097(93)90310-w.
8
Efficacy of diltiazem for control of symptoms of coronary arterial spasm.
Am J Cardiol. 1980 Dec 1;46(6):1027-32. doi: 10.1016/0002-9149(80)90362-8.
9
Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan.药物治疗变异型心绞痛：日本11所心脏病学研究所的调查
Circulation. 1981 Apr;63(4):844-8. doi: 10.1161/01.cir.63.4.844.
10
Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm.因冠状动脉痉挛导致无症状心肌缺血的患者出现危及生命的室性心律失常。
N Engl J Med. 1992 May 28;326(22):1451-5. doi: 10.1056/NEJM199205283262202.
Zotero 插件